Guest commentator: David Latshaw, Ph.D., MBA, CEO & Co-Founder, BioPhy, @BioPhy3 

How can companies utilize artificial intelligence to drive their decision-making?

Artificial intelligence tools are quickly being adopted throughout virtually all industries, demonstrating that when the stakes are high, AI can provide an edge at all levels of an organization. In the last decade, there have been significant advances in the field of AI, which have powered revolutionary tools for computer-assisted decision-making. We've seen the advent of navigation apps able to analyze real-time traffic conditions and propose the best routes, personally tailored content and purchase recommendations for every online customer, and automated medical advisors that allow doctors to diagnose illnesses that humans might not otherwise detect. All these innovations were made possible by AI. During my career, I've seen firsthand how the AI algorithms I helped build were crucial to the historically swift launch and delivery of the Johnson & Johnson COVID-19 vaccine.  

The simple strength behind AI-supported decision-making is that it allows humans to incorporate and analyze far more information than any one person (and, in some cases, even whole teams) could do on their own.  

Companies can use AI to recognize patterns to capture the upside. 

With the appropriate data, AI can be used to analyze and inform decision-making. For example, an AI platform can be used to optimize pricing. When fed data about product sales, advertising efforts, and customer base, an AI platform can make recommendations about pricing based on things like geographic region, time of year, shifting customer demographics, recession, or any other number of relevant variables. Implementing such predictive dynamic pricing could generate greater growth and profits. 

Companies can use AI to manage uncertainty by making informed predictions. 

Given the right data and techniques, an AI platform can be trained to predict future events and even simulate the results of proposed decisions. For example, a life sciences company seeking to select a target drug for research and development could consult with an AI platform to choose the drug most likely to pass its clinical trials (a critical barrier to bringing a drug to market). Likewise, this same AI tool could also be used to inform the company how best to structure its clinical trials to maximize the likelihood of regulatory approval. AI-enhanced predictions allow companies to make better strategic decisions.  

Companies can use AI to understand complex relationships between disparate subject matter to enhance outcomes.  

AI tools are particularly useful when applied to multidisciplinary problems that span too many disparate subject areas for a single human reviewer to understand and analyze. For example, in the clinical trial analysis example above, the reviewer would need to objectively assess not only the expected safety and efficacy of the treatment but also the company's own operational competencies in bringing this kind of therapeutic to market. An AI platform, unlike the human reviewer, can span multiple fields and simultaneously analyze things like biological features, corporate financials, the company's team composition, and patient population. Moreover, the AI platform can use this data to create objective, standardized, and unbiased metrics for decision-making that can be used to easily compare any one target drug to another. Understanding these complex relationships can unlock tremendous value for investors and management teams. 

In short, in today's competitive and uncertain business environment, top-performing companies are finding new ways to apply AI technology to optimize their decision-making, while slow adopters risk falling behind their peers. 

More About the Life Sciences Action Team 

The Life Sciences Action Team (LSAT) is a unique, cross-functional group of 150+ regional leaders from life sciences companies and their supporting industries. The group comes together to forge new business connections and solve challenges — specifically related to business attraction, talent, and advocacy to advance Greater Philadelphia's economic competitiveness. 

Upcoming Event 

Advancing Pennsylvania's Regional Innovation Economy 

Tuesday, December 6, 2022 | 8:30 AM – 10:30 AM | The Conference Center at Penn State Great Valley 

In 2019 we heard from leaders from the Commonwealth who were pioneering new initiatives in their communities to drive innovation, prosperity, and investments. At that time, the Brookings Institute had released a report on the state of Pennsylvania's innovation economy compared with other states. This report showed us how we compare to other states in advancing an innovation economy in significant and incremental ways.  

Join us for the release of the Brookings Institute's newest report focusing solely on Pennsylvania's innovation economy. The report highlights Pennsylvania's key innovation sectors and outlines what the new administration in Harrisburg can do to invigorate the Commonwealth's economy. 

This is an opportunity to have your voice heard in Harrisburg. Attendees will participate in an interactive dialogue with Mark Muro, Senior Fellow and Policy Director at the Metropolitan Policy Program, and Rob Maxim, Senior Research Associate at Brookings, about what Pennsylvania's new Governor should include in a bold, innovative economic agenda. Ideas generated at this session will be shared with the new administration and cabinet post-event.